美沙拉嗪联合复方谷氨酰胺治疗溃疡性结肠炎的疗效  

The Efficacy of Mesalazine Combined with Compound Glutamine in the Treatment of Ulcerative Colitis

作　　者：黄鹏 梁晴晴 王明超 HUANG Peng;LIANG Qingqing;WANG Mingchao(Department of Gastroenterology,Shenhuo Group General Hospital,Shangqiu Henan 476600)

机构地区：[1]河南省神火集团总医院消化内科,河南商丘476600

出　　处：《医学临床研究》2025年第3期441-443,共3页Journal of Clinical Research

摘　　要：【目的】探讨美沙拉嗪联合复方谷氨酰胺治疗溃疡性结肠炎(UC)的疗效。【方法】102例UC患者,随机分为对照组与观察组,每组51例。对照组采用美沙拉嗪治疗,观察组采用美沙拉嗪联合复方谷氨酰胺治疗,比较两组治疗后结肠功能指标(腹胀、腹泻改善时间,大便次数及性状完全恢复时间),治疗前后肠黏膜屏障功能指标[二胺氧化酶(DAO)、D-乳酸水平]、炎症因子[肿瘤坏死因子-α(TNF-α)、C反应蛋白(CRP)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)]水平及病变活跃度(肠黏膜病变评分、Mayo活动指数评分)。【结果】治疗前,两组患者各项指标比较,差异均无统计学意义(P>0.05);治疗后,观察组患者腹胀、腹泻改善时间,大便次数及性状完全恢复时间均显著短于对照组(P<0.05),观察组患者DAO、D-乳酸、TNF-α、CRP、IL-8水平及肠黏膜病变评分、Mayo活动指数评分均显著低于对照组,IL-10水平高于对照组(P<0.05)。【结论】美沙拉嗪联合复方谷氨酰胺治疗能够显著优化UC患者的结肠功能和病变活跃度,明显改善肠黏膜屏障功能,降低炎症因子水平。【Objective】To explore the efficacy of mesalazine combined with compound glutamine in the treatment of ulcerative colitis(UC).【Methods】A total of 102 UC patients were randomly divided into a control group and an observation group,with 51 cases in each group.Patients in the control group received mesalazine treatment,while those in the observation group received mesalazine combined with compound glutamine.The outcomes,colonic function(improvement time in bloating,diarrhea,and complete recovery time of stool frequency and form/properties),intestinal mucosal barrier function[levels of diamine oxidase(DAO)and D-lactic acid,inflammatory markers(tumor necrosis factor-alpha(TNF-α),C-reactive protein(CRP),interleukin-8(IL-8),interleukin-(IL-10))],and disease activity(intestinal mucosal lesion score,Mayo activity index score)were compared between the two groups before and after treatment.【Results】Before treatment,there were no statistically significant differences in the indices between the two groups(P>0.05).After treatment,the observation group showed significantly shorter improvement times for bloating and diarrhea,as well as faster complete recovery of stool frequency and form compared to the control group(P<0.05).Additionally,the DAO,D-lactic acid,TNF-α,CRP,IL-8 levels,intestinal mucosal lesion score,and Mayo activity index score in the observation group were significantly lower than those in the control group,while IL-10 level in the observation group was higher than that in the control group(P<0.05).【Conclusion】Mesalazine combined with compound glutamine significantly optimizes colonic function and disease activity in UC patients,improves intestinal mucosal barrier function,and reduces inflammation markers.

关 键 词：结肠炎 溃疡性 氨水杨酸 谷氨酰胺 治疗结果 

分 类 号：R574.62[医药卫生—消化系统]